Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CLPT ClearPoint Neuro Inc
- Stocks
- Healthcare
- NYSEAMERICAN: CLPT
Price (delayed)
$13.18
Market cap
$368.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.76
Enterprise value
$359.95M
ClearPoint Neuro's mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of
Highlights
CLPT's debt has shrunk by 75% YoY and by 3.6% QoQ
The gross profit has grown by 32% YoY and by 3.2% from the previous quarter
ClearPoint Neuro's EPS has decreased by 9% from the previous quarter but it has increased by 8% YoY
The equity has contracted by 42% YoY and by 21% from the previous quarter
ClearPoint Neuro's net income has decreased by 10% from the previous quarter
Key stats
What are the main financial stats of CLPT
Market
Valuations
Earnings
Shares outstanding
27.99M
Market cap
$368.9M
Enterprise value
$359.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
18.22
Price to sales (P/S)
11.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.17
Revenue
$32.24M
Gross profit
$19.73M
Operating income
-$21.68M
Net income
-$20.79M
EBIT
-$20.78M
EBITDA
-$19.01M
Free cash flow
-$11.74M
Per share
Balance sheet
Liquidity
EPS
-$0.76
EPS diluted
-$0.76
Free cash flow per share
-$0.42
Book value per share
$0.72
Revenue per share
$1.16
TBVPS
$1.06
Total assets
$30.07M
Total liabilities
$10.08M
Debt
$3.44M
Equity
$19.99M
Working capital
$17.35M
Debt to equity
0.17
Current ratio
3.53
Quick ratio
2.34
Net debt/EBITDA
0.47
Margins
Efficiency
Dividend
EBITDA margin
-59%
Gross margin
61.2%
Net margin
-64.5%
Operating margin
-67.2%
Return on assets
-51.3%
Return on equity
-78.1%
Return on invested capital
-150.6%
Return on capital employed
-89.5%
Return on sales
-64.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CLPT stock price
How has the ClearPoint Neuro stock price performed over time
Intraday
2.01%
1 week
-6.59%
1 month
14.41%
1 year
105.94%
YTD
-14.3%
QTD
10.85%
Financial performance
How have ClearPoint Neuro's revenue and profit performed over time
Revenue
$32.24M
Gross profit
$19.73M
Operating income
-$21.68M
Net income
-$20.79M
Gross margin
61.2%
Net margin
-64.5%
The gross profit has grown by 32% YoY and by 3.2% from the previous quarter
ClearPoint Neuro's revenue has increased by 23% YoY and by 2.7% from the previous quarter
CLPT's net margin is up by 18% YoY but it is down by 7% QoQ
ClearPoint Neuro's operating margin has increased by 16% YoY but it has decreased by 7% from the previous quarter
Price vs fundamentals
How does CLPT's price correlate with its fundamentals
Growth
What is ClearPoint Neuro's growth rate over time
Valuation
What is ClearPoint Neuro stock price valuation
P/E
N/A
P/B
18.22
P/S
11.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.17
ClearPoint Neuro's EPS has decreased by 9% from the previous quarter but it has increased by 8% YoY
The P/B is 58% below the 5-year quarterly average of 43.3 but 51% above the last 4 quarters average of 12.1
The equity has contracted by 42% YoY and by 21% from the previous quarter
ClearPoint Neuro's revenue has increased by 23% YoY and by 2.7% from the previous quarter
The price to sales (P/S) is 17% higher than the last 4 quarters average of 9.7 but 12% lower than the 5-year quarterly average of 12.9
Efficiency
How efficient is ClearPoint Neuro business performance
ClearPoint Neuro's return on invested capital has shrunk by 73% YoY and by 14% QoQ
CLPT's ROA is down by 26% from the previous quarter and by 17% YoY
The return on equity has declined by 25% since the previous quarter
ClearPoint Neuro's ROS has increased by 18% YoY but it has decreased by 7% from the previous quarter
Dividends
What is CLPT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CLPT.
Financial health
How did ClearPoint Neuro financials performed over time
The company's total assets is 198% higher than its total liabilities
ClearPoint Neuro's total liabilities has decreased by 47% YoY and by 27% from the previous quarter
The company's total assets fell by 44% YoY and by 23% QoQ
CLPT's debt is 83% lower than its equity
CLPT's debt has shrunk by 75% YoY and by 3.6% QoQ
The debt to equity has dropped by 58% year-on-year but it has increased by 21% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.